Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Saksela

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|April 18, 1998
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activitiesV Joukov, V Kumar, T Sorsa, et al.
The Journal of Biological Chemistry|October 5, 1985
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectinE M Salonen, O Saksela, T Vartio, et al.
Digestive Diseases and Sciences|August 5, 1998
Induction of proliferation in isolated guinea pig gastric epithelium during restitution after superficial injuryA Bhowmik, H Paimela, T Joutsi, et al.
Biochemical and Biophysical Research Communications|February 26, 1993
Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cellsL Pertovaara, J Tienari, S Vainikka, et al.
The Journal of Biological Chemistry|March 4, 1994
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cellsL Pertovaara, A Kaipainen, T Mustonen, et al.
International Journal of Cancer|February 20, 1991
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogenE Koivunen, O Saksela, O Itkonen, et al.
The Journal of Cell Biology|April 1, 1987
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsJ Pöllänen, O Saksela, E M Salonen, et al.
Journal of Supramolecular Structure|January 1, 1976
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cellsA Vaheri, E Ruoslahti, E Linder, et al.
The British Journal of Dermatology|December 25, 2016
Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanomaN Neittaanmäki, M Salmivuori, I Pölönen, et al.
The EMBO Journal|January 15, 1996
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesV Joukov, K Pajusola, A Kaipainen, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|April 18, 1998
A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activitiesV Joukov, V Kumar, T Sorsa, et al.
The Journal of Biological Chemistry|October 5, 1985
Plasminogen and tissue-type plasminogen activator bind to immobilized fibronectinE M Salonen, O Saksela, T Vartio, et al.
Digestive Diseases and Sciences|August 5, 1998
Induction of proliferation in isolated guinea pig gastric epithelium during restitution after superficial injuryA Bhowmik, H Paimela, T Joutsi, et al.
Biochemical and Biophysical Research Communications|February 26, 1993
Modulation of fibroblast growth factor receptor expression and signalling during retinoic acid-induced differentiation of Tera-2 teratocarcinoma cellsL Pertovaara, J Tienari, S Vainikka, et al.
The Journal of Biological Chemistry|March 4, 1994
Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cellsL Pertovaara, A Kaipainen, T Mustonen, et al.
International Journal of Cancer|February 20, 1991
Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogenE Koivunen, O Saksela, O Itkonen, et al.
The Journal of Cell Biology|April 1, 1987
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsJ Pöllänen, O Saksela, E M Salonen, et al.
Journal of Supramolecular Structure|January 1, 1976
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cellsA Vaheri, E Ruoslahti, E Linder, et al.
The British Journal of Dermatology|December 25, 2016
Hyperspectral imaging in detecting dermal invasion in lentigo maligna melanomaN Neittaanmäki, M Salmivuori, I Pölönen, et al.
The EMBO Journal|January 15, 1996
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinasesV Joukov, K Pajusola, A Kaipainen, et al.
Pageof 8